Mechanism of action of SNS-032, a novel cyclin dependent kinase inhibitor, in chronic lymphocytic leukemia: Comparison with flavopiridol.

被引：3
|
作者：
Chen, Rong [1 ]
Wierda, William G. [1 ]
Benaissa, Sherri [1 ]
Hoch, Ute [2 ]
Hawtin, Rachael E. [2 ]
Fox, Judith A. [2 ]
Keating, Michael J. [1 ]
Gandhi, Varsha [1 ]
Plunkett, William [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Sunesis Pharmaceut, San Francisco, CA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3112.3112
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3112
引用
收藏
页码：915A / 915A
页数：1
相关论文
共 50 条
  • [41] Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms
    Senderowicz, AM
    Headlee, D
    Stinson, SF
    Lush, RM
    Kalil, N
    Villalba, L
    Hill, K
    Steinberg, SM
    Figg, WD
    Tompkins, A
    Arbuck, SG
    Sausville, EA
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 2986 - 2999
  • [42] CYCLIN-DEPENDENT KINASE INHIBITOR FLAVOPIRIDOL ENHANCES CYTOTOXIC ACTION OF DNA-DAMAGING AGENTS ON HUMAN GLIOMA CELLS
    Hirose, Yuichi
    Ohba, Shigeo
    Kawase, Takeshi
    Sano, Hirotoshi
    NEURO-ONCOLOGY, 2009, 11 (02) : 222 - 222
  • [43] Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin-dependent kinase inhibitors
    Kubczak, Malgorzata
    Szustka, Aleksandra
    Blonski, Jerzy Z.
    Gucky, Tomas
    Misiewicz, Malgorzata
    Krystof, Vladmir
    Robak, Pawel
    Rogalinska, Malgorzata
    MOLECULAR MEDICINE REPORTS, 2019, 19 (05) : 3593 - 3603
  • [44] Contribution of Cyclin Dependent Kinase Inhibitor 1A Genotypes to Childhood Acute Lymphocytic Leukemia Risk in Taiwan
    Chen, Chao-chun
    Tsai, Chung-lin
    Pei, Jen-sheng
    Tzeng, Huey-en
    Hsu, Pei-chen
    Cheng, Da-chuan
    Lin, Jiunn-cherng
    Tsai, Chia-wen
    Bau, Da-tian
    Chang, Wen-shin
    CANCER GENOMICS & PROTEOMICS, 2025, 22 (01) : 46 - 54
  • [45] Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia
    Tsirigotis, P
    Pappa, V
    Labropoulos, S
    Papageorgiou, S
    Kontsioti, F
    Dervenoulas, J
    Papageorgiou, E
    Panani, A
    Mantzios, G
    Economopoulos, T
    Raptis, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (03) : 230 - 236
  • [46] Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study
    Stadler, WM
    Vogelzang, NJ
    Amato, R
    Sosman, J
    Taber, D
    Liebowitz, D
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 371 - 375
  • [47] Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis
    Patel, V
    Senderowicz, AM
    Pinto, D
    Igishi, T
    Raffeld, M
    Quintanilla-Martinez, L
    Ensley, JF
    Sausville, EA
    Gutkind, JS
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (09): : 1674 - 1681
  • [48] Cyclin-Dependent Kinase 7/9 Inhibitor SNS-032 Abrogates FIP1-like-1 Platelet-Derived Growth Factor Receptor α and Bcr-Abl Oncogene Addiction in Malignant Hematologic Cells
    Wu, Yongbin
    Chen, Chun
    Sun, Xiaoyong
    Shi, Xianping
    Jin, Bei
    Ding, Ke
    Yeung, Sai-Ching Jim
    Pan, Jingxuan
    CLINICAL CANCER RESEARCH, 2012, 18 (07) : 1966 - 1978
  • [49] Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells
    Patel, Viralkumar
    Balakrishnan, Kumudha
    Bibikova, Elena
    Ayres, Mary
    Keating, Michael J.
    Wierda, William G.
    Gandhi, Varsha
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3734 - 3743
  • [50] Strategic combination of the cyclin-dependent kinase inhibitor CYC065 with venetoclax to target anti-apoptotic proteins in chronic lymphocytic leukemia
    Chen, Rong
    Chen, Yuling
    Frame, Sheelagh
    Blake, David
    Wierda, William G.
    Zheleva, Daniella
    Plunkett, William
    CANCER RESEARCH, 2018, 78 (13)
12345